LIVIVO - Search results -

Search results

Result 1 - 10 of total 46

Search options

Article ; Online: An update on: molecular genetics of high-risk chronic lymphocytic leukemia.

Moia, Riccardo / Patriarca, Andrea / Deambrogi, Clara / Rasi, Silvia / Favini, Chiara / Kodipad, Ahad Ahmed / Schipani, Mattia / Gaidano, Gianluca

Expert review of hematology

2019 Volume 13, Issue 2, Page(s) 109–116

Abstract: ... ...

Abstract	Introduction
MeSH term(s)	Antineoplastic Agents/therapeutic use ; Biomarkers, Tumor ; Drug Resistance, Neoplasm/drug effects ; Drug Resistance, Neoplasm/genetics ; Humans ; Leukemia, Lymphocytic, Chronic, B-Cell/drug therapy ; Leukemia, Lymphocytic, Chronic, B-Cell/genetics ; Leukemia, Lymphocytic, Chronic, B-Cell/metabolism ; Proto-Oncogene Proteins c-bcl-2/antagonists & inhibitors ; Proto-Oncogene Proteins c-bcl-2/genetics ; Proto-Oncogene Proteins c-bcl-2/metabolism ; Tumor Suppressor Protein p53/genetics ; Tumor Suppressor Protein p53/metabolism
Chemical Substances	Antineoplastic Agents ; BCL2 protein, human ; Biomarkers, Tumor ; Proto-Oncogene Proteins c-bcl-2 ; TP53 protein, human ; Tumor Suppressor Protein p53
Language	English
Publishing date	2019-11-30
Publishing country	England
Document type	Journal Article ; Research Support, Non-U.S. Gov't ; Review ; Video-Audio Media
ZDB-ID	2516804-6
ISSN	1747-4094 ; 1747-4086
ISSN (online)	1747-4094
ISSN	1747-4086
DOI	10.1080/17474086.2020.1697225
Database	MEDical Literature Analysis and Retrieval System OnLINE

Full text online

Accessible to users with ZB MED library card

In stock of ZB MED Cologne/Königswinter

Zs.A 6943: Show issues

Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular
ab Jg. 2022: Lesesaal (EG)

Order via subito

This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.

Details ▾

Article ; Online: Inducible T-cell co-stimulator (ICOS) and ICOS ligand are novel players in the multiple-myeloma microenvironment.

Boggio, Elena / Gigliotti, Casimiro Luca / Moia, Riccardo / Scotta, Annamaria / Crespi, Ilaria / Boggione, Paola / De Paoli, Lorenzo / Deambrogi, Clara / Garzaro, Massimiliano / Vidali, Matteo / Chiocchetti, Annalisa / Stoppa, Ian / Rolla, Roberta / Dianzani, Chiara / Monge, Chiara / Clemente, Nausicaa / Gaidano, Gianluca / Dianzani, Umberto

British journal of haematology

2021 Volume 196, Issue 6, Page(s) 1369–1380

Abstract: The inducible T-cell co-stimulator (ICOS) is a T-cell receptor that, once bound to ICOS ligand (ICOSL) expressed on several cell types including the B-cell lineage, plays a decisive role in adaptive immunity by regulating the interplay between B and T ... ...

Abstract	The inducible T-cell co-stimulator (ICOS) is a T-cell receptor that, once bound to ICOS ligand (ICOSL) expressed on several cell types including the B-cell lineage, plays a decisive role in adaptive immunity by regulating the interplay between B and T cells. In addition to its immunomodulatory functions, we have shown that ICOS/ICOSL signalling can inhibit the activity of osteoclasts, unveiling a novel mechanism of lymphocyte-bone cells interactions. ICOS and ICOSL can also be found as soluble forms, namely sICOS and sICOSL. Here we show that: (i) levels of sICOS and sICOSL are increased in multiple myeloma (MM) compared to monoclonal gammopathy of undetermined significance and smouldering MM; (ii) levels of sICOS and sICOSL variably correlate with several markers of tumour burden; and (iii) sICOS levels tend to be higher in Durie-Salmon stage II/III versus stage I MM and correlate with overall survival as an independent variable. Moreover, surface ICOS and ICOSL are expressed in both myeloma cells and normal plasma cells, where they probably regulate different functional stages. Finally, ICOSL triggering inhibits the migration of myeloma cell lines in vitro and the growth of ICOSL
MeSH term(s)	Humans ; Inducible T-Cell Co-Stimulator Ligand/metabolism ; Inducible T-Cell Co-Stimulator Protein/metabolism ; Ligands ; Multiple Myeloma/metabolism ; T-Lymphocytes ; Tumor Microenvironment
Chemical Substances	ICOS protein, human ; Inducible T-Cell Co-Stimulator Ligand ; Inducible T-Cell Co-Stimulator Protein ; Ligands
Language	English
Publishing date	2021-12-26
Publishing country	England
Document type	Journal Article ; Research Support, Non-U.S. Gov't
ZDB-ID	80077-6
ISSN	1365-2141 ; 0007-1048
ISSN (online)	1365-2141
ISSN	0007-1048
DOI	10.1111/bjh.17968
Database	MEDical Literature Analysis and Retrieval System OnLINE

Full text online

Accessible to users with ZB MED library card

In stock of ZB MED Cologne/Königswinter

Uh III Zs.182: Show issues

Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular
ab Jg. 2022: Lesesaal (EG)

Order via subito

Details ▾

Article ; Online: Anatomical heterogeneity of residual disease in chronic lymphocytic leukemia treated with ibrutinib.

Hematological oncology

2022 Volume 40, Issue 5, Page(s) 1105–1108

MeSH term(s)	Humans ; Leukemia, Lymphocytic, Chronic, B-Cell/drug therapy ; Neoplasm, Residual
Language	English
Publishing date	2022-06-08
Publishing country	England
Document type	Letter
ZDB-ID	604884-5
ISSN	1099-1069 ; 0278-0232
ISSN (online)	1099-1069
ISSN	0278-0232
DOI	10.1002/hon.3039
Database	MEDical Literature Analysis and Retrieval System OnLINE

Full text online

Accessible to users with ZB MED library card

In stock of ZB MED Cologne/Königswinter

Zs.A 1816: Show issues

Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
Jg. 1995 - 2021: Lesesall (1.OG)
ab Jg. 2022: Lesesaal (EG)

Order via subito

Details ▾

Article ; Online: MYC network mutations in high-risk chronic lymphocytic leukaemia.

Monti, Sara / Deambrogi, Clara / Rinaldi, Andrea / Bertoni, Francesco / Gaidano, Gianluca / Rossi, Davide

Hematological oncology

2014 Volume 32, Issue 3, Page(s) 155–157

MeSH term(s)	Gene Expression Regulation, Leukemic ; Gene Regulatory Networks ; Humans ; Leukemia, Lymphocytic, Chronic, B-Cell/genetics ; Mutation ; Proto-Oncogene Proteins c-myc/genetics
Chemical Substances	Proto-Oncogene Proteins c-myc
Language	English
Publishing date	2014-09
Publishing country	England
Document type	Letter ; Research Support, Non-U.S. Gov't
ZDB-ID	604884-5
ISSN	1099-1069 ; 0278-0232
ISSN (online)	1099-1069
ISSN	0278-0232
DOI	10.1002/hon.2117
Database	MEDical Literature Analysis and Retrieval System OnLINE

Full text online

Accessible to users with ZB MED library card

In stock of ZB MED Cologne/Königswinter

Zs.A 1816: Show issues

Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
Jg. 1995 - 2021: Lesesall (1.OG)
ab Jg. 2022: Lesesaal (EG)

Order via subito

Details ▾

Article ; Online: A randomized clinical study on the impact of Comprehensive Geriatric Assessment (CGA) based interventions on the quality of life of elderly, frail, onco-hematologic patients candidate to anticancer therapy: protocol of the ONCO-Aging study.

BMC geriatrics

2021 Volume 21, Issue 1, Page(s) 320

Abstract: Background: Age is considered as one of the most important risk-factor for many types of solid and hematological cancers, as their incidence increases with age in parallel to the ever-growing elderly population. Moreover, cancer incidence is constantly ... ...

Abstract	Background: Age is considered as one of the most important risk-factor for many types of solid and hematological cancers, as their incidence increases with age in parallel to the ever-growing elderly population. Moreover, cancer incidence is constantly increasing as a consequence of the increase in life expectancy that favors the process of cellular senescence. Geriatric assessment has been increasingly recognized as predictive and prognostic instrument to detect frailty in older adults with cancer. In particular, the G8 score is a simple and reproducible instrument to identify elderly patients who should undergo full geriatric evaluation. Due to their frailty, elderly patients may be often under-treated and a therapeutic choice based also on a comprehensive geriatric assessment (CGA) is recommended. With these premises, we aim to test the impact of the CGA based interventions on the quality of life (QoL) of frail elderly onco-hematological patients, identified by the G8 screening, candidate for innovative target directed drugs or treatments including the combination of radiotherapy and chemotherapy (RT + CT). Methods: Patients aged > 65 years, candidate to target directed agents or to RT + CT treatments are screened for frailty by the G8 test; those patients classified as frail (G8 ≤ 14) are randomized to receive a CGA at baseline or to conventional care. The primary endpoint is QoL, assessed by EORTC QLQ-C30C. As collateral biological study, the potential prognostic/predictive role of T-cell senescence and myeloid derived suppressor cells (MDSC) are evaluated on plasma samples. Discussion: This trial will contribute to define the impact of CGA on the management of frail elderly onco-hematologic patients candidate to innovative biological drugs or to integrated schedules with the association of RT + CT. Furthermore, the use of plasma samples to assess the potential prognostic value of imbalance of immune-competent cells is expected to contribute to the individualized care of elderly patients, resulting into a fine tuning of the therapeutic strategies. Trial registration: ClinicalTrials.gov ID: NCT04478916 . registered July 21, 2020 - retrospectively registered.
MeSH term(s)	Aged ; Aging ; Frail Elderly ; Frailty/diagnosis ; Frailty/epidemiology ; Frailty/therapy ; Geriatric Assessment ; Humans ; Quality of Life ; Randomized Controlled Trials as Topic
Language	English
Publishing date	2021-05-19
Publishing country	England
Document type	Clinical Trial Protocol ; Journal Article ; Research Support, Non-U.S. Gov't
ZDB-ID	2059865-8
ISSN	1471-2318 ; 1471-2318
ISSN (online)	1471-2318
ISSN	1471-2318
DOI	10.1186/s12877-021-02237-3
Database	MEDical Literature Analysis and Retrieval System OnLINE

Order via subito

Article ; Online: Ibrutinib dose intensity in high-risk chronic lymphocytic leukemia.

Forestieri, Gabriela / Terzi di Bergamo, Lodovico / Deodato, Marina / Frustaci, Anna Maria / Moia, Riccardo / Deambrogi, Clara / Rasi, Silvia / Autore, Francesco / Merli, Michele / Mattarucchi, Roberta / Fahrni, Gaby / Scarfo', Lydia / Gussetti, Daniela / Bulian, Pietro / Zanatta, Annagiulia / Spina, Valeria / Bruscaggin, Alessio / Pini, Katia / Piffaretti, Deborah /

Pirosa, Maria Cristina / Salehi, Matin / Marques de Almeida, Joyce / Passweg, Jakob / Cavalli, Franco / Zucca, Emanuele / Gerber, Bernhard / Stussi, Georg / Gattei, Valter / Ghia, Paolo / Gregor, Michael / Passamonti, Francesco / Laurenti, Luca / Gaidano, Gianluca / Tedeschi, Alessandra / Rossi, Davide / Condoluci, Adalgisa

Hematological oncology

2022 Volume 40, Issue 5, Page(s) 1100–1104

MeSH term(s)	Humans ; Leukemia, Lymphocytic, Chronic, B-Cell/drug therapy
Language	English
Publishing date	2022-06-01
Publishing country	England
Document type	Letter ; Comment
ZDB-ID	604884-5
ISSN	1099-1069 ; 0278-0232
ISSN (online)	1099-1069
ISSN	0278-0232
DOI	10.1002/hon.3032
Database	MEDical Literature Analysis and Retrieval System OnLINE

Full text online

Accessible to users with ZB MED library card

In stock of ZB MED Cologne/Königswinter

Zs.A 1816: Show issues

Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
Jg. 1995 - 2021: Lesesall (1.OG)
ab Jg. 2022: Lesesaal (EG)

Order via subito

Details ▾

Article ; Online: Diffuse large B-cell lymphoma genotyping on the liquid biopsy.

Rossi, Davide / Diop, Fary / Spaccarotella, Elisa / Monti, Sara / Zanni, Manuela / Rasi, Silvia / Deambrogi, Clara / Spina, Valeria / Bruscaggin, Alessio / Favini, Chiara / Serra, Roberto / Ramponi, Antonio / Boldorini, Renzo / Foà, Robin / Gaidano, Gianluca

Blood

2017 Volume 129, Issue 14, Page(s) 1947–1957

Abstract: Accessible and real-time genotyping for diagnostic, prognostic, or treatment purposes is increasingly impelling in diffuse large B-cell lymphoma (DLBCL). Cell-free DNA (cfDNA) is shed into the blood by tumor cells undergoing apoptosis and can be used as ... ...

Abstract	Accessible and real-time genotyping for diagnostic, prognostic, or treatment purposes is increasingly impelling in diffuse large B-cell lymphoma (DLBCL). Cell-free DNA (cfDNA) is shed into the blood by tumor cells undergoing apoptosis and can be used as source of tumor DNA for the identification of DLBCL mutations, clonal evolution, and genetic mechanisms of resistance. In this study, we aimed at tracking the basal DLBCL genetic profile and its modification upon treatment using plasma cfDNA. Ultra-deep targeted next generation sequencing of pretreatment plasma cfDNA from DLBCL patients correctly discovered DLBCL-associated mutations that were represented in >20% of the alleles of the tumor biopsy with >90% sensitivity and ∼100% specificity. Plasma cfDNA genotyping also allowed for the recovery of mutations that were undetectable in the tissue biopsy, conceivably because, due to spatial tumor heterogeneity, they were restricted to clones that were anatomically distant from the biopsy site. Longitudinal analysis of plasma samples collected under rituximab-cyclophosphamide-doxorubicin-vincristine-prednisone (R-CHOP) chemotherapy showed a rapid clearance of DLBCL mutations from cfDNA among responding patients. Conversely, among patients who were resistant to R-CHOP, basal DLBCL mutations did not disappear from cfDNA. In addition, among treatment-resistant patients, new mutations were acquired in cfDNA that marked resistant clones selected during the clonal evolution. These results demonstrate that cfDNA genotyping of DLBCL is as accurate as genotyping of the diagnostic biopsy to detect clonally represented somatic tumor mutations and is a real-time and noninvasive approach to tracking clonal evolution and the emergence of treatment-resistant clones.
MeSH term(s)	Antibodies, Monoclonal, Murine-Derived/administration & dosage ; Antineoplastic Combined Chemotherapy Protocols/administration & dosage ; Biopsy ; Cyclophosphamide/administration & dosage ; Doxorubicin/administration & dosage ; Female ; Follow-Up Studies ; Genotyping Techniques ; High-Throughput Nucleotide Sequencing ; Humans ; Lymphoma, Large B-Cell, Diffuse/blood ; Lymphoma, Large B-Cell, Diffuse/drug therapy ; Lymphoma, Large B-Cell, Diffuse/genetics ; Lymphoma, Large B-Cell, Diffuse/pathology ; Male ; Mutation ; Prednisone/administration & dosage ; Prospective Studies ; Rituximab ; Vincristine/administration & dosage
Chemical Substances	Antibodies, Monoclonal, Murine-Derived ; R-CHOP protocol ; Rituximab (4F4X42SYQ6) ; Vincristine (5J49Q6B70F) ; Doxorubicin (80168379AG) ; Cyclophosphamide (8N3DW7272P) ; Prednisone (VB0R961HZT)
Language	English
Publishing date	2017-01-17
Publishing country	United States
Document type	Clinical Trial ; Journal Article ; Observational Study
ZDB-ID	80069-7
ISSN	1528-0020 ; 0006-4971
ISSN (online)	1528-0020
ISSN	0006-4971
DOI	10.1182/blood-2016-05-719641
Database	MEDical Literature Analysis and Retrieval System OnLINE

In stock of ZB MED Cologne/Königswinter

Uh III Zs.140: Show issues			Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular ab Jg. 2022: Lesesaal (EG)
Zs.MO 364: Show issues

Order via subito

Details ▾
- See ZB MED holdings
- Order with fees

Article ; Online: Digital PCR improves the quantitation of DMR and the selection of CML candidates to TKIs discontinuation.

Bernardi, Simona / Malagola, Michele / Zanaglio, Camilla / Polverelli, Nicola / Dereli Eke, Elif / D'Adda, Mariella / Farina, Mirko / Bucelli, Cristina / Scaffidi, Luigi / Toffoletti, Eleonora / Deambrogi, Clara / Stagno, Fabio / Bergamaschi, Micaela / Franceschini, Luca / Abruzzese, Elisabetta / Divona, Maria Domenica / Gobbi, Marco / Di Raimondo, Francesco / Gaidano, Gianluca /

Tiribelli, Mario / Bonifacio, Massimiliano / Cattaneo, Chiara / Iurlo, Alessandra / Russo, Domenico

Cancer medicine

2019 Volume 8, Issue 5, Page(s) 2041–2055

Abstract: Treatment-free remission (TFR) by tyrosine kinase inhibitors (TKI) discontinuation in patients with deep molecular response (DMR) is a paramount goal in the current chronic myeloid leukemia (CML) therapeutic strategy. The best DMR level by real-time ... ...

Abstract	Treatment-free remission (TFR) by tyrosine kinase inhibitors (TKI) discontinuation in patients with deep molecular response (DMR) is a paramount goal in the current chronic myeloid leukemia (CML) therapeutic strategy. The best DMR level by real-time quantitative PCR (RT-qPCR) for TKI discontinuation is still a matter of debate. To compare the accuracy of digital PCR (dPCR) and RT-qPCR for BCR-ABL1 transcript levels detection, 142 CML patients were monitored for a median time of 24 months. Digital PCR detected BCR-ABL1 transcripts in the RT-qPCR undetectable cases. The dPCR analysis of the samples, grouped by the MR classes, revealed a significant difference between MR
MeSH term(s)	Adult ; Aged ; Aged, 80 and over ; Cohort Studies ; Female ; Fusion Proteins, bcr-abl/genetics ; Gene Expression Regulation, Neoplastic ; Humans ; Leukemia, Myelogenous, Chronic, BCR-ABL Positive/drug therapy ; Leukemia, Myelogenous, Chronic, BCR-ABL Positive/genetics ; Male ; Middle Aged ; Neoplasm, Residual/diagnosis ; Neoplasm, Residual/genetics ; Polymerase Chain Reaction/methods ; Protein Kinase Inhibitors/therapeutic use ; Sensitivity and Specificity ; Treatment Outcome ; Young Adult
Chemical Substances	Protein Kinase Inhibitors ; Fusion Proteins, bcr-abl (EC 2.7.10.2)
Language	English
Publishing date	2019-04-04
Publishing country	United States
Document type	Comparative Study ; Journal Article ; Research Support, Non-U.S. Gov't
ISSN	2045-7634
ISSN (online)	2045-7634
DOI	10.1002/cam4.2087
Database	MEDical Literature Analysis and Retrieval System OnLINE

Order via subito

Inter-library loan at ZB MED

Your chosen title can be delivered directly to ZB MED Cologne location if you are registered as a user at ZB MED Cologne.

Article ; Online: Clinical impact of small subclones harboring NOTCH1, SF3B1 or BIRC3 mutations in chronic lymphocytic leukemia.

Rasi, Silvia / Khiabanian, Hossein / Ciardullo, Carmela / Terzi-di-Bergamo, Lodovico / Monti, Sara / Spina, Valeria / Bruscaggin, Alessio / Cerri, Michaela / Deambrogi, Clara / Martuscelli, Lavinia / Biasi, Alessandra / Spaccarotella, Elisa / De Paoli, Lorenzo / Gattei, Valter / Foà, Robin / Rabadan, Raul / Gaidano, Gianluca / Rossi, Davide

Haematologica

2016 Volume 101, Issue 4, Page(s) e135–8

MeSH term(s)	Alleles ; Antineoplastic Agents/therapeutic use ; B-Lymphocytes/metabolism ; B-Lymphocytes/pathology ; Baculoviral IAP Repeat-Containing 3 Protein ; Clone Cells ; Gene Expression ; Gene Frequency ; High-Throughput Nucleotide Sequencing ; Humans ; Inhibitor of Apoptosis Proteins/genetics ; Inhibitor of Apoptosis Proteins/metabolism ; Leukemia, Lymphocytic, Chronic, B-Cell/drug therapy ; Leukemia, Lymphocytic, Chronic, B-Cell/genetics ; Leukemia, Lymphocytic, Chronic, B-Cell/mortality ; Leukemia, Lymphocytic, Chronic, B-Cell/pathology ; Mutation ; Phosphoproteins/genetics ; Phosphoproteins/metabolism ; Prospective Studies ; RNA Splicing Factors/genetics ; RNA Splicing Factors/metabolism ; Receptor, Notch1/genetics ; Receptor, Notch1/metabolism ; Survival Analysis ; Ubiquitin-Protein Ligases/genetics ; Ubiquitin-Protein Ligases/metabolism
Chemical Substances	Antineoplastic Agents ; Inhibitor of Apoptosis Proteins ; NOTCH1 protein, human ; Phosphoproteins ; RNA Splicing Factors ; Receptor, Notch1 ; SF3B1 protein, human ; BIRC3 protein, human (EC 2.3.2.27) ; Baculoviral IAP Repeat-Containing 3 Protein (EC 2.3.2.27) ; Ubiquitin-Protein Ligases (EC 2.3.2.27)
Language	English
Publishing date	2016-04
Publishing country	Italy
Document type	Letter ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't
ZDB-ID	2333-4
ISSN	1592-8721 ; 0017-6567 ; 0390-6078
ISSN (online)	1592-8721
ISSN	0017-6567 ; 0390-6078
DOI	10.3324/haematol.2015.136051
Database	MEDical Literature Analysis and Retrieval System OnLINE

Full text online

Full text

In stock of ZB MED Cologne/Königswinter

Uh III Zs.76: Show issues

Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular
ab Jg. 2022: Lesesaal (EG)

Order via subito

Details ▾

Article ; Online: Analysis of the REL, BCL11A, and MYCN proto-oncogenes belonging to the 2p amplicon in chronic lymphocytic leukemia.

Deambrogi, Clara / De Paoli, Lorenzo / Fangazio, Marco / Cresta, Stefania / Rasi, Silvia / Spina, Valeria / Gattei, Valter / Gaidano, Gianluca / Rossi, Davide

American journal of hematology

2010 Volume 85, Issue 7, Page(s) 541–544

MeSH term(s)	Aged ; Aged, 80 and over ; Carrier Proteins/genetics ; Chromosomes, Human, Pair 2 ; Female ; Gene Expression Profiling ; Gene Expression Regulation, Neoplastic ; Genes, rel/genetics ; Humans ; Leukemia, Lymphocytic, Chronic, B-Cell/genetics ; Leukemia, Lymphocytic, Chronic, B-Cell/mortality ; Male ; Middle Aged ; N-Myc Proto-Oncogene Protein ; Nuclear Proteins/genetics ; Oncogene Proteins/genetics ; Prognosis ; Proto-Oncogenes/genetics ; Repressor Proteins ; Survival Analysis ; Up-Regulation
Chemical Substances	BCL11A protein, human ; Carrier Proteins ; MYCN protein, human ; N-Myc Proto-Oncogene Protein ; Nuclear Proteins ; Oncogene Proteins ; Repressor Proteins
Keywords	covid19
Language	English
Publishing date	2010-06-23
Publishing country	United States
Document type	Letter ; Research Support, Non-U.S. Gov't
ZDB-ID	196767-8
ISSN	1096-8652 ; 0361-8609
ISSN (online)	1096-8652
ISSN	0361-8609
DOI	10.1002/ajh.21742
Database	MEDical Literature Analysis and Retrieval System OnLINE

Full text online

Accessible to users with ZB MED library card

In stock of ZB MED Cologne/Königswinter

Zs.A 1251: Show issues

Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
Jg. 1995 - 2021: Lesesall (1.OG)
ab Jg. 2022: Lesesaal (EG)

Order via subito

Details ▾

To top

Full text online

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

Full text online

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

Full text online

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

Full text online

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

More links

Kategorien

Order via subito

Full text online

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

More links

Kategorien

Order via subito

Inter-library loan at ZB MED

Full text online

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

Full text online

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito